National MS Society Awards $12M to 40 Research Projects in US and Elsewhere
The National Multiple Sclerosis Society (NMSS) has pledged $12 million to support 40 new, multi-year research projects focused on “stopping…
Articles by Diogo Pinto
Cannabidiol-derived Treatment for MS, EHP-101, Enters Phase 1 Safety Study, Emerald Health Says
Emerald Health Pharmaceuticals announced that it has begun enrolling healthy volunteers for a Phase 1 clinical trial evaluating the safety…
New Assessment Tool Shows Effect of Social Networks on MS Patient Outcomes
A person’s social network can have an effect on their functional disability. This is what researchers discovered when they applied…
With Age, Depression Lessens and Quality of Life Improves in MS Patients, Researchers Report
A recent study found that elder individuals with multiple sclerosis (MS) experience significantly less severe depressive symptoms and…
Processing Speed Training May Help Improve Cognitive Function in MS Patients, Pilot Study Suggests
A brain training technique that helps boost processing speed was seen to significantly improve the cognitive capacity of multiple…
Phase 3 Trial in UK Soon to Test Statin, Simvastatin, in Slowing SPMS Progression
A large Phase 3 trial getting underway at sites across the U.K. will test the effectiveness of simvastatin, a widely…
NICE Rules Against Bringing Ocrevus into NHS for Primary Progressive Patients in UK
The National Institute for Health and Care Excellence, better known as NICE, issued a final decision against including Ocrevus…
Active Biotech Regains Full Rights to Laquinimod from Teva, Plans to Continue Work on Potential MS Oral Therapy
Active Biotech announced it has regained global development and commercialization rights over laquinimod, its investigational oral therapy for…
Sexual Problems Common Among MS Patients But Often Ignored, Study Reports
Sexual problems are a frequent but unreported symptom of multiple sclerosis (MS) that affects other symptoms patients experience with this disease,…
Ice Water Test Can Improve Bladder Dysfunction Diagnosis in MS Patients, Study Finds
The ice water test, a tool used to evaluate the function of the bladder in patients with neurological disorders, was…
Healthy Diet May Lower Risk of Developing MS, Study Finds
People who eat a healthy diet that includes foods such as vegetables, fish, eggs, poultry, and legumes may have a reduced…
Pregnancy Worsens Symptoms in MS Patients, Study Finds
Pregnancy, including successful delivery or miscarriage, worsens symptoms of multiple sclerosis (MS), as well as onset of the disease, a…
Brain Changes in CIS Patients May Be to Blame for Depression, Reduced Quality of Life, Study Suggests
Changes in the brains of patients with clinically isolated syndrome (CIS), the first clinical presentation of multiple sclerosis (MS),…
#EAN2018 – Slowly Evolving Lesions Monitored Using MTR Scans May Be Marker of SPMS Progression
An MRI technique known as magnetization transfer ratio (MTR) correlated closely with the progression of slowly evolving lesions (SELs) — a specific type…
Common Air Pollutants Not Linked to MS Development, Canadian Population Study Reports
Long-term exposure to three common air pollutants — fine particulate matter, nitrogen dioxide, and ozone — were not found to be…
Family Support and Identity Seen to Affect Depression, Mood Swings in MS Patients in UK Study
A survey of multiple sclerosis (MS) patients that looked at their sense of social identity based on their family relations —…
HPV Vaccine Not Seen to Raise Risk of Autoimmune Disease in Canadian Study
Girls given the quadrivalent human papillomavirus (HPV4) vaccination, commercialized as Gardasil, showed no increased risk of developing autoimmune diseases like…
European EMA Confirms Severe Risks Associated with MS Medicine Zinbryta
A review of data concerning the multiple sclerosis (MS) medicine Zinbryta (daclizumab) confirmed its association with the risk…
Sativex Can Improve Driving Ability of MS Patients, Study Says
Sativex, a cannabis-based anti-spasticity medicine commercialized as oromucosal spray by GW Pharmaceuticals, improves the driving ability of patients…
Rehabilitation Technique Improves Limb Movement in MS Patients, Phase 2 Trial Shows
Constraint-induced movement therapy (CIMT), a rehabilitation technique originally developed for stroke patients, may also be effective in improving limb use…
Two Factors Lead to Better Outcomes when Disease-modifying Therapies Stopped, Study Finds
A lot of people with multiple sclerosis take disease-modifying therapies to reduce the inflammation associated with the disease — but in…
MS Patients Are Among the Most Satisfied with Their Healthcare, Surveys Show
Multiple sclerosis patients are among those with debilitating diseases who are most satisfied with their healthcare, two surveys indicate. Others…
Pain Affect in MS Associated with Physical and Psychiatric Comorbidities
Physical and psychiatric comorbidities in multiple sclerosis (MS) patients are associated with an increased risk of experiencing more pain — namely pain…
Dysport Therapeutic Approved by Health Canada for Lower Limb Spasticity Treatment in Adults
AbobotulinumtoxinA, marketed as Dysport Therapeutic by Ipsen Biopharmaceuticals Canada, was approved by Health Canada for the treatment of…
Novartis, Pear Collaborating on Digital Therapeutics to Treat MS, Schizophrenia
Novartis and Pear Therapeutics are joining forces to develop novel prescription digital therapeutics to treat patients with schizophrenia…
High Fish Consumption May Be Key to Lowering Risk of Developing MS
Eating fish once a week, or one to three times per month along with taking daily fish oil supplements, may…